scholarly article | Q13442814 |
P50 | author | Alan Fenwick | Q50307321 |
Russell Stothard | Q55303062 | ||
Simon Brooker | Q56762824 | ||
Narcis B Kabatereine | Q56762863 | ||
Edridah M Tukahebwa | Q56762882 | ||
Artemis Koukounari | Q59988709 | ||
Joanne P. Webster | Q67877771 | ||
P2093 | author name string | Yaobi Zhang | |
Francis Kazibwe | |||
Fiona M Fleming | |||
P2860 | cites work | Control of Schistosoma mansoni and intestinal helminths: 8-year follow-up of an urban school programme in Bujumbura, Burundi | Q39387669 |
Hemoquant determination of hookworm-related blood loss and its role in iron deficiency in African children | Q39492306 | ||
A community-based randomized trial of praziquantel to control schistosomiasis morbidity in schoolchildren in Zambia | Q39497041 | ||
Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment. | Q41484277 | ||
Hookworm control as a strategy to prevent iron deficiency | Q41582192 | ||
Parasitic infections, anaemia and nutritional status: a study of their interrelationships and the effect of prophylaxis and treatment on workers in Kwale District, Kenya | Q41921906 | ||
Schistosomiasis and soil-transmitted helminth infections: forging control efforts | Q42147194 | ||
The impact of a school health programme on the prevalence and morbidity of urinary schistosomiasis in Mwera Division, Pangani District, Tanzania | Q43342666 | ||
Community perception of school-based delivery of anthelmintics in Ghana and Tanzania | Q43414547 | ||
Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity | Q43904275 | ||
New initiatives against Africa's worms | Q44641296 | ||
Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni | Q45192925 | ||
A field trial using praziquantel (BiltricideR) to treat Schistosoma mansoni and Schistosoma haematobium infection in Gezira, Sudan | Q46475815 | ||
Relationships of Schistosoma hematobium, hookworm and malarial infections and metrifonate treatment to hemoglobin level in Kenyan school children | Q46534525 | ||
Anaemia caused by asymptomatic plasmodium falciparum infection in semi-immune african schoolchildren | Q47861826 | ||
Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity twenty-three months after treatment with praziquantel | Q68109476 | ||
Dynamic models of schistosomiasis morbidity | Q71244456 | ||
Better health, nutrition and education for the school-aged child. The Partnership for Child Development | Q73203487 | ||
The health and nutritional status of schoolchildren in Africa: evidence from school-based health programmes in Ghana and Tanzania. The Partnership for Child Development | Q77711851 | ||
The cost of large-scale school health programmes which deliver anthelmintics to children in Ghana and Tanzania. The Partnership for Child Development | Q78180275 | ||
Evaluation of efficacy of school-based anthelmintic treatments against anaemia in children in the United Republic of Tanzania | Q28350276 | ||
Planning chemotherapy based schistosomiasis control: validation of a mathematical model using data on Schistosoma haematobium from Pemba, Tanzania | Q33179863 | ||
Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact | Q33589623 | ||
Design and analysis issues in cluster-randomized trials of interventions against infectious diseases | Q34006485 | ||
The impact of chemotherapy on morbidity due to schistosomiasis | Q35126805 | ||
Drugs for the control of parasitic diseases: current status and development in schistosomiasis | Q35569078 | ||
Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control | Q35680581 | ||
Evaluating the epidemiological impact of national control programmes for helminths | Q35912008 | ||
Spatial analysis of the distribution of intestinal nematode infections in Uganda | Q35989165 | ||
Human schistosomiasis and anemia: the relationship and potential mechanisms | Q36169020 | ||
Conquering schistosomiasis in China: the long march | Q36324372 | ||
The development of an age structured model for schistosomiasis transmission dynamics and control and its validation forSchistosoma mansoni | Q36503901 | ||
Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda | Q38454931 | ||
Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. | Q38879183 | ||
Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda | Q38881798 | ||
Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control | Q38882358 | ||
Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence | Q38882377 | ||
Evidence for a long-term effect of a single dose of praziquantel on Schistosoma mansoni-induced hepatosplenic lesions in northern Uganda | Q38886669 | ||
Epidemiological and control aspects of schistosomiasis in Brazilian endemic areas. | Q38954750 | ||
Issues in the design and interpretation of studies to evaluate the impact of community-based interventions | Q39138986 | ||
Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire | Q39385067 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Uganda | Q1036 |
P1104 | number of pages | 9 | |
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 91-99 | |
P577 | publication date | 2007-02-01 | |
P1433 | published in | Bulletin of the World Health Organization | Q2928049 |
P1476 | title | Impact of a national helminth control programme on infection and morbidity in Ugandan schoolchildren | |
P478 | volume | 85 |
Q92510183 | A Search for Snail-Related Answers to Explain Differences in Response of Schistosoma mansoni to Praziquantel Treatment among Responding and Persistent Hotspot Villages along the Kenyan Shore of Lake Victoria |
Q38854033 | A centenary of Robert T. Leiper's lasting legacy on schistosomiasis and a COUNTDOWN on control of neglected tropical diseases |
Q35075083 | A latent Markov modelling approach to the evaluation of circulating cathodic antigen strips for schistosomiasis diagnosis pre- and post-praziquantel treatment in Uganda |
Q21562256 | A research agenda for helminth diseases of humans: Intervention for control and elimination |
Q21144498 | A research agenda for helminth diseases of humans: The problem of helminthiases |
Q21562257 | A research agenda for helminth diseases of humans: Towards control and elimination |
Q28539669 | A school-based cross-sectional survey of adverse events following co-administration of albendazole and praziquantel for preventive chemotherapy against urogenital schistosomiasis and soil-transmitted helminthiasis in Kwale County, Kenya |
Q39142089 | A single FLOTAC is more sensitive than triplicate Kato-Katz for the diagnosis of low-intensity soil-transmitted helminth infections |
Q28534849 | A very high infection intensity of Schistosoma mansoni in a Ugandan Lake Victoria Fishing Community is required for association with highly prevalent organ related morbidity |
Q52610773 | Albendazole Treatment Improves Work Capacity in Women Smallholder Farmers Infected with Hookworm: A Double-Blind Randomized Control Trial. |
Q39409682 | An audacious goal: the elimination of schistosomiasis in our lifetime through mass drug administration |
Q38852112 | An extensive burden of giardiasis associated with intestinal schistosomiasis and anaemia in school children on the shoreline of Lake Albert, Uganda |
Q28752190 | An updated atlas of human helminth infections: the example of East Africa |
Q38869597 | Anaemia in Ugandan preschool-aged children: the relative contribution of intestinal parasites and malaria |
Q33294065 | Anaemia: a useful indicator of neglected disease burden and control |
Q28475501 | Analysis of complex patterns of human exposure and immunity to Schistosomiasis mansoni: the influence of age, sex, ethnicity and IgE |
Q62486477 | Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity |
Q38660139 | Change in children's school behavior after mass administration of praziquantel for Schistosoma mansoni infection in endemic areas of western Kenya: A pilot study using the Behavioral Assessment System for Children (BASC-2). |
Q34001292 | Closing the praziquantel treatment gap: new steps in epidemiological monitoring and control of schistosomiasis in African infants and preschool-aged children |
Q35016101 | Community perceptions, attitude, practices and treatment seeking behaviour for schistosomiasis in L. Victoria islands in Uganda |
Q34629346 | Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes |
Q33833108 | Confirmed local endemicity and putative high transmission of Schistosoma mansoni in the Sesse Islands, Lake Victoria, Uganda |
Q34331536 | Control of neglected tropical diseases needs a long-term commitment |
Q37087378 | Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up |
Q35805295 | De-politicizing parasites: reflections on attempts to control the control of neglected tropical diseases |
Q36284173 | Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis |
Q43924383 | Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis. |
Q44072486 | Defining the Necessary Next Steps for Effective Control of Helminthic Infections |
Q37330975 | Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali |
Q37026044 | Deworming the world |
Q51144224 | Diet and hygiene practices influence morbidity in schoolchildren living in Schistosomiasis endemic areas along Lake Victoria in Kenya and Tanzania-A cross-sectional study |
Q34510642 | Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda |
Q36803942 | Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni. |
Q36506153 | Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections |
Q42906063 | Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel. |
Q36204615 | Estimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes |
Q39583417 | Evaluation and application of potential schistosome-associated morbidity markers within large-scale mass chemotherapy programmes. |
Q33847447 | Evaluation of mammalian and intermediate host surveillance methods for detecting schistosomiasis reemergence in southwest China. |
Q28476200 | Geographical distribution of intestinal schistosomiasis and soil-transmitted helminthiasis and preventive chemotherapy strategies in Sierra Leone |
Q60932194 | Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study |
Q34571264 | Heterogeneities and consequences of Plasmodium species and hookworm coinfection: a population based study in Uganda |
Q84507812 | High levels of Schistosoma mansoni infections among schoolchildren in central Sudan one year after treatment with praziquantel |
Q39002259 | Host-parasite relations and implications for control |
Q50532009 | Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study |
Q37037295 | Impact of two rounds of praziquantel mass drug administration on Schistosoma mansoni infection prevalence and intensity: a comparison between community wide treatment and school based treatment in western Kenya |
Q34341901 | In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections |
Q35065331 | Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda |
Q35825988 | Influence of Schistosoma mansoni and Hookworm Infection Intensities on Anaemia in Ugandan Villages |
Q35721392 | Integrated prevalence mapping of schistosomiasis, soil-transmitted helminthiasis and malaria in lakeside and island communities in Lake Victoria, Uganda |
Q36248914 | Intestinal helminth infections and nutritional status of children attending primary schools in Wakiso District, Central Uganda |
Q37625862 | Intestinal schistosomiasis in Uganda at high altitude (>1400 m): malacological and epidemiological surveys on Mount Elgon and in Fort Portal crater lakes reveal extra preventive chemotherapy needs |
Q58643310 | Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A |
Q57296452 | Low Praziquantel Treatment Coverage for in Mayuge District, Uganda, Due to the Absence of Treatment Opportunities, Rather Than Systematic Non-Compliance |
Q38877241 | Malaria and hookworm infections in relation to haemoglobin and serum ferritin levels in pregnancy in Masindi district, western Uganda |
Q28607740 | Malaria, anaemia and under-nutrition: three frequently co-existing conditions among preschool children in rural Rwanda |
Q34134448 | Mass drug administration significantly reduces infection of Schistosoma mansoni and hookworm in school children in the national control program in Sierra Leone |
Q38895404 | Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting |
Q33486177 | Molecular epidemiology of Schistosoma mansoni in Uganda: DNA barcoding reveals substantial genetic diversity within Lake Albert and Lake Victoria populations. |
Q64095900 | Non-invasive surveillance of Plasmodium infection by real-time PCR analysis of ethanol preserved faeces from Ugandan school children with intestinal schistosomiasis |
Q28476209 | Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study |
Q38927082 | One hundred years of neglect in paediatric schistosomiasis |
Q33296532 | Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. |
Q21562254 | Partnering parasites: evidence of synergism between heavy Schistosoma haematobium and Plasmodium species infections in Kenyan children |
Q91735806 | Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel |
Q36195856 | Plasmodium infection, anaemia and mosquito net use among school children across different settings in Kenya |
Q33503219 | Polyparasite helminth infections and their association to anaemia and undernutrition in Northern Rwanda |
Q33805145 | Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study. |
Q64089349 | Prevalence and clinical outcomes of Plasmodium falciparum and intestinal parasitic infections among children in Kiryandongo refugee camp, mid-Western Uganda: a cross sectional study |
Q33869191 | Prevalence of Anaemia and Associated Risk Factors among Children in North-western Uganda: A Cross Sectional Study |
Q36256196 | Prevalence of Schistosomes and Soil-Transmitted Helminths among Schoolchildren in Lake Victoria Basin, Tanzania |
Q56910300 | Prevalence, intensity and factors associated with soil-transmitted helminths infections among preschool-age children in Hoima district, rural western Uganda |
Q38873931 | Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programme |
Q28485197 | Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection |
Q37557676 | Prospects for the control of neglected tropical diseases by mass drug administration |
Q35665650 | Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model. |
Q30397196 | Rapid mapping of schistosomiasis and other neglected tropical diseases in the context of integrated control programmes in Africa. |
Q36089146 | Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration |
Q37461456 | Remote sensing, geographical information system and spatial analysis for schistosomiasis epidemiology and ecology in Africa |
Q60044656 | Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial |
Q36209379 | Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel |
Q33796476 | Schistosoma mansoni Infections in young children: when are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable? |
Q35856989 | Schistosoma mansoni among pre-school children in Musozi village, Ukerewe Island, North-Western-Tanzania: prevalence and associated risk factors |
Q37493576 | Schistosoma mansoni infection after three years of mass drug administration in Sierra Leone |
Q36450651 | Schistosoma mansoni morbidity among school-aged children: a SCORE project in Kenya |
Q96762042 | Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis |
Q28542928 | Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment |
Q28481702 | Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment |
Q28547483 | Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial |
Q37310901 | Southern Sudan: an opportunity for NTD control and elimination? |
Q34997628 | Spatial heterogeneity of haemoglobin concentration in preschool-age children in sub-Saharan Africa |
Q33328716 | Strongyloides stercoralis: a field-based survey of mothers and their preschool children using ELISA, Baermann and Koga plate methods reveals low endemicity in western Uganda. |
Q58862731 | Surveillance of intestinal schistosomiasis during control: a comparison of four diagnostic tests across five Ugandan primary schools in the Lake Albert region |
Q30645103 | The Lake Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA): study protocol for a randomised controlled trial |
Q39002257 | The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008. |
Q34496260 | The effect of a health communication campaign on compliance with mass drug administration for schistosomiasis control in western Kenya--the SCORE project |
Q33637297 | The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial |
Q33437988 | The epidemiology and control of urinary schistosomiasis and soil-transmitted helminthiasis in schoolchildren on Unguja Island, Zanzibar |
Q37278516 | The impact of an 8-year mass drug administration programme on prevalence, intensity and co-infections of soil-transmitted helminthiases in Burundi |
Q34245720 | The role of nutrition in integrated programs to control neglected tropical diseases |
Q39196853 | Towards nationwide control of schistosomiasis in Yemen: a pilot project to expand treatment to the whole community |
Q37113146 | Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso |
Q35793397 | Understanding Heterogeneity in the Impact of National Neglected Tropical Disease Control Programmes: Evidence from School-Based Deworming in Kenya |
Q38871350 | Understanding ethnic differences in behaviour relating to Schistosoma mansoni re-infection after mass treatment |
Q28487697 | Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross sectional study |
Q37655256 | Using the hierarchical ordinal regression model to analyse the intensity of urinary schistosomiasis infection in school children in Lusaka Province, Zambia |
Q28477145 | Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review |
Search more.